Wikidata

(Q64789133)

English

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433

clinical trial

In more languages

Statements

title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 (English)
0 references
country
American Samoa
0 references
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Bosnia and Herzegovina
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Croatia
0 references
Denmark
0 references
Egypt
0 references
Estonia
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Latvia
0 references
Lithuania
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Serbia
0 references
Singapore
0 references
Slovakia
0 references
Slovenia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
21 March 2018
0 references
end time
31 January 2022
0 references
number of participants
738
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64789133&oldid=1858036690"